Focal Nodular Hyperplasia: Causes and Treatment

Focal nodular hyperplasia (FNH) is a non-cancerous liver condition characterized by the development of a benign mass of liver cells. This growth forms a distinct nodule within the liver and is typically discovered incidentally during imaging tests for other reasons. The exact cause of FNH is not completely understood, but it is believed to be related to abnormal blood flow within the liver.

Factors such as hormonal changes, certain medications, or preexisting liver conditions may contribute to the development of FNH. While FNH is generally considered a benign condition and does not typically cause symptoms or complications, it is essential for healthcare providers to monitor and evaluate these nodules to ensure proper management. If you have been diagnosed with FNH, your healthcare

Symptoms of Focal Nodular Hyperplasia

Focal nodular hyperplasia (FNH) is a benign liver condition that may not cause symptoms in many cases. However, some individuals with FNH may experience abdominal pain, which can range from mild discomfort to more severe pain.

Other possible symptoms include a feeling of fullness in the abdomen, nausea, or a mass that can be felt in the upper right side of the abdomen. It is essential to consult a healthcare provider for a proper diagnosis and guidance if experiencing any of these symptoms.

Many patients with focal nodular hyperplasia experience no symptoms at all, especially if the lesion is small.
When symptoms do occur, they may include abdominal pain or discomfort, particularly in the upper right quadrant.
Some individuals may notice a palpable mass in the abdomen, which could be attributed to the presence of the lesion.
In rare cases, focal nodular hyperplasia can lead to complications like rupture or compression of nearby structures.
Jaundice or other signs of liver dysfunction may manifest if the lesion affects the liver's normal function.

Get a second opinion from trusted experts and makeconfident, informed decisions.

Get Second Opinion

Causes of Focal Nodular Hyperplasia

Focal nodular hyperplasia (FNH) is a benign liver condition with various potential causes. While the exact etiology remains unclear, several factors are believed to contribute to its development. These include abnormal blood flow patterns within the liver, hormonal influences, and genetic predispositions. Additionally, certain risk factors, such as oral contraceptive use, history of liver trauma, or underlying vascular malformations, may also play a role in the pathogenesis of FNH. Understanding these underlying factors can help clinicians better diagnose and manage patients with focal nodular hyperplasia.

Hormonal factors, such as estrogen dominance, can contribute to the development of focal nodular hyperplasia in the liver.
Genetics plays a role in some cases of focal nodular hyperplasia, with certain genetic mutations predisposing individuals to this benign liver lesion.
Use of certain medications, such as hormone replacement therapy or anabolic steroids, has been linked to the development of focal nodular hyperplasia.
Liver injury or inflammation from conditions like hepatitis or cirrhosis can sometimes lead to the formation of focal nodular hyperplasia.
Vascular abnormalities or alterations in blood flow within the liver can contribute to the development of focal nodular hyperplasia.

Types Of Focal Nodular Hyperplasia

Focal nodular hyperplasia (FNH) presents in various forms, including typical, atypical, and mixed types. The typical FNH features a central scar with characteristic radiological findings, making it distinguishable from other liver lesions. Atypical FNH lacks a central scar and may exhibit more complex imaging features, posing a diagnostic challenge.

Mixed FNH combines elements of both typical and atypical forms, presenting a hybrid appearance on imaging studies. Understanding the different types of FNH is crucial for accurate diagnosis and appropriate management of patients with these liver lesions.

Typical focal nodular hyperplasia (FNH) presents as a solitary lesion in the liver.
Atypical FNH may show multiple nodules or exhibit atypical radiological features.
FNH with central scar is a common variant characterized by a central stellate scar.
Large FNH can measure more than 5 cm in diameter and may have an increased risk of complications.
Pediatric FNH is a subtype that occurs in children and presents with specific clinical and imaging features.
Fibrous FNH is a rare variant with prominent fibrous tissue within the lesion.
Inflammatory FNH may display inflammatory changes, mimicking other liver pathologies.
Atypical vascular patterns in FNH can be seen on imaging studies,

Risk Factors

While the exact cause of FNH is not fully understood, certain risk factors have been identified. These include the use of oral contraceptives, hormone replacement therapy, and conditions like hepatic adenoma and vascular malformations in the liver. Additionally, FNH has been associated with underlying liver diseases such as cirrhosis and hepatitis C. Understanding these risk factors can help in identifying individuals who may be at a higher risk of developing focal nodular hyperplasia and guide appropriate management strategies.

Oral contraceptive use, especially in women with a history of prolonged hormonal therapy, is a known risk factor for focal nodular hyperplasia.
Presence of underlying vascular abnormalities or disorders, such as hepatic vascular malformations, can increase the likelihood of developing focal nodular hyperplasia.
Exposure to certain environmental toxins or chemicals, such as vinyl chloride or thorium dioxide, has been associated with an increased risk of focal nodular hyperplasia.
Genetic factors, including specific gene mutations or hereditary conditions like hereditary hemorrhagic telangiectasia, can predispose individuals to focal nodular hyperplasia.
Chronic liver diseases, such as hepatic cirrhosis or hepatitis C infection, are potential risk factors for the

Your health is everything - prioritize your well-being today.

Schedule Your Appointment

Diagnosis of Focal Nodular Hyperplasia

Blood tests may be done to assess liver function and rule out other conditions. In some cases, a liver biopsy may be performed to confirm the diagnosis by examining a sample of the liver tissue under a microscope. Imaging findings showing a central scar with radiating fibrous septa are key indicators of focal nodular hyperplasia. It is essential for healthcare providers to consider the patient's medical history and symptoms in conjunction with these diagnostic tests to accurately diagnose and differentiate focal nodular hyperplasia from other liver lesions.

Imaging studies such as MRI or CT scans are used to visualize the characteristic features of focal nodular hyperplasia.
Blood tests may be conducted to assess liver function and rule out other liver conditions.
Biopsy may be performed to confirm the diagnosis by examining a sample of the liver tissue.
Sometimes a contrast-enhanced ultrasound is used to evaluate blood flow within the lesion.
Differential diagnosis is essential to distinguish focal nodular hyperplasia from other liver lesions or tumors.

Treatment for Focal Nodular Hyperplasia

Focal nodular hyperplasia, a benign liver lesion, typically does not require treatment unless it causes symptoms or poses a diagnostic challenge. In cases where intervention is necessary, options include close monitoring through imaging studies to track any changes over time, surgical resection for larger or symptomatic lesions, and arterial embolization to cut off blood supply to the lesion.

The choice of treatment depends on the size, location, and symptoms associated with the lesion, with the goal of preserving liver function and relieving any discomfort or concerns for the patient.

Surgical resection is a common treatment for focal nodular hyperplasia, especially in symptomatic or enlarging lesions.
Radiological procedures such as arterial embolization or radiofrequency ablation may be utilized to shrink or destroy the lesion.
Observation with regular monitoring through imaging studies may be recommended for small, asymptomatic lesions that show no signs of growth or complications.
Medication is not typically used to treat focal nodular hyperplasia but may be prescribed to manage symptoms or address underlying conditions.

Find Our Specialists

Book Doctor Appointment